98 related articles for article (PubMed ID: 29875947)
1. [Toxidermy mimicking acute chemotherapy-induced lupus erythematosus].
Kharmoum S; Soughi M
Pan Afr Med J; 2018; 29():66. PubMed ID: 29875947
[TBL] [Abstract][Full Text] [Related]
2. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
Wong NY; Parsons LM; Trotter MJ; Tsang RY
BMC Res Notes; 2014 Nov; 7():785. PubMed ID: 25369825
[TBL] [Abstract][Full Text] [Related]
4. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
5. Taxane associated subacute cutaneous lupus erythematosus.
Marchetti MA; Noland MM; Dillon PM; Greer KE
Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.
Geraminejad P; Stone MS; Sontheimer RD
Lupus; 2004; 13(6):473-7. PubMed ID: 15303576
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
[No Abstract] [Full Text] [Related]
8. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.
Miller KK; Chu J; Patel R; Kamino H
Dermatol Online J; 2011 Oct; 17(10):3. PubMed ID: 22031629
[TBL] [Abstract][Full Text] [Related]
10. Subacute cutaneous lupus erythematosus starting as linear lupus erythematosus.
Frances L; Betlloch I; Leiva-Salinas M; Marin I; Pascual JC
Int J Dermatol; 2016 Feb; 55(2):173-6. PubMed ID: 26235783
[TBL] [Abstract][Full Text] [Related]
11. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
13. Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Ferrero JM; Hardy-Bessard AC; Capitain O; Lortholary A; Salles B; Follana P; Herve R; Deblock M; Dauba J; Atlassi M; Largillier R
Cancer; 2016 Oct; 122(20):3119-3126. PubMed ID: 27412268
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
Adachi A; Horikawa T
J Dermatol; 2007 Jul; 34(7):473-6. PubMed ID: 17584326
[TBL] [Abstract][Full Text] [Related]
15. [A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
Suzuki M
Gan To Kagaku Ryoho; 2007 Jan; 34(1):69-72. PubMed ID: 17220673
[TBL] [Abstract][Full Text] [Related]
16. A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer.
Silva O; Lopes G; Morgenzstern D; Lobo C; Doliny P; Santos E; Abdullah S; Gautam U; Reis I; Welsh C; Slingerland J; Hurley J; Gluck S
Clin Breast Cancer; 2008 Apr; 8(2):162-7. PubMed ID: 18621613
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus in a patient with progressive systemic sclerosis.
Aiempanakit K; Chiratikarnwong K; Juthong S; Auepemkiate S
Lupus; 2018 Oct; 27(11):1860-1863. PubMed ID: 30028256
[TBL] [Abstract][Full Text] [Related]
18. Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.
Martín M; Ruiz Simón A; Ruiz Borrego M; Ribelles N; Rodríguez-Lescure Á; Muñoz-Mateu M; González S; Margelí Vila M; Barnadas A; Ramos M; Del Barco Berron S; Jara C; Calvo L; Martínez-Jáñez N; Mendiola Fernández C; Rodríguez CA; Martínez de Dueñas E; Andrés R; Plazaola A; de la Haba-Rodríguez J; López-Vega JM; Adrover E; Ballesteros AI; Santaballa A; Sánchez-Rovira P; Baena-Cañada JM; Casas M; del Carmen Cámara M; Carrasco EM; Lluch A
J Clin Oncol; 2015 Nov; 33(32):3788-95. PubMed ID: 26416999
[TBL] [Abstract][Full Text] [Related]
19. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
Lebowitz PF; Eng-Wong J; Swain SM; Berman A; Merino MJ; Chow CK; Venzon D; Zia F; Danforth D; Liu E; Zujewski J
Clin Cancer Res; 2004 Oct; 10(20):6764-9. PubMed ID: 15501952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
